CompletedPhase 2NCT00309842
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Principal Investigator
- Claudio G. Brunstein, MD, PhD, FNP-BCMasonic Cancer Center, University of Minnesota
- Intervention
- filgrastim(biological)
- Enrollment
- 213 enrolled
- Eligibility
- 55 years · All sexes
- Timeline
- 2005 – 2019
Study locations (2)
- Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
- Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00309842 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.